selected publications article Longterm safety, efficacy, and inhibition of structural damage progression over 5 years of treatment with abatacept in patients with rheumatoid arthritis in the abatacept in inadequate responders to methotrexate trial. Journal of Rheumatology. 41:1077-1087. 2014-01-01
